Tackling The Problem Of Fake Medicines
Tech, Regs And Education Key To Keeping Supply Chain -- And Patients -- Safe
Executive Summary
Despite a raft of measures to prevent substandard or falsified (SF) medicines from reaching individuals, these medicines proliferated with the growth of e-commerce during the COVID-19 pandemic. The problem requires multistakeholder counter efforts, and for providers and patients to change their behaviors.